Essentials 1.2 Pharma Flashcards
(231 cards)
What is the clinical use for Metformin?
Diabetes (Type II)
What Class Does Glipizide Belong To?
Sulfonylureas
What is the MOA of Glipizide?
It is Insulin secretagogue.
Glipizide binds to sulfonylurea receptor on β-cells and causes insulin secretion
What Class Does Canagliflozin Belong To?
It is a Sodium-glucose co-transporter 2 (SGLT2) inhibitors
What is the MOA of Sodium-glucose co-transporter 2 (SGLT2) inhibitors?
Block reabsorption of glucose by SGLT 2 in the proximal tubule of the kidney causing glycosuria
What Medications are SGLT2 Inhibitors
Canagliflozin
What is the MOA of Sulfonylureas?
They Are insulin secretagogue. They function by binding to sulfonylurea receptors on β-cells and cause insulin secretion.
What Medication is a Sulfonylureas?
Glipizide
What is the MOA of Metformin
4 Main Principles
Reduces hepatic glucose production
Increase glucose absorption in muscle
Increase insulin sensitivity
Decrease intestinal glucose absorption
What are Glucagon-like polypeptide-1 (GLP-1) receptor agonists?
They acts as analog of GLP1 which stimulates glucose-induced insulin secretion, suppresses glucagon, delays gastric emptying, and possibly improves beta cell function, causing weight loss
What Medications are GLP1 Agonists?
Liraglutide and Semaglutide-
Think Medications ending in “-glutide”
What is the MOA of Dipeptidyl peptidase-4 (DPP4 Inhibitors)?
Inhibits the enzyme that breaks down GLP-1, raising GLP-1 levels
What Medications are DPP4 Inhibitors?
Sitagliptin
What is the Mechanism of Actions of -Statins
Reversible competitive inhibitors of 3-hydroxy-3methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol synthesis.
This increases synthesis and reduces degradation of LDL receptors; therefore more LDL receptors on surface of hepatocytes=increased removal of LDL from blood
What 3 Medications are the most commonly used -Statins
Rosuvastatin, Atorvastatin, Simvastatin
What is the MOA of the drug class PCSK9 Inhibitors (Proprotein convertase subtilisin/kexin type 9)?
PCSK9 is a protein that binds to the LDL receptor, and reduces the LDL receptor density. This increases circulating LDL.
PCSK9 inhibitors are human monoclonal antibodies that block this process, increase LDL receptors and decrease circulating LDL.
What Medications are PCSK9 Inhibitors?
Alirocumab
What is the clinical use for Glipizide?
Diabetes (Type II)
What is the clinical use for Canagliflozin?
Diabetes (Type II)
What is the MOA of Fenofibrate
Agonist for the nuclear transcription factor PPAR-α which increases lipolysis and decreases triglycerides
What is the MOA of Ezetimibe?
Selective inhibitor of cholesterol absorption from the small intestine via the sterol transporter NPC1L
What is the MOA of Glucocorticoid Medications
Replaces endogenous cortisol and causes inhibition of phospholipase A2
This leads to↓ Cyclooxygenase (prostaglandins, leukotriene), Cytokines (Tumor necrosis factor, IL-3,4,5,13, Granulocyte-Macrophage Stimulating factor).
What Medications act as Glucocorticoids?
Prednisone, prednisolone, hydrocortisone, dexamethasone